Structural basis for broad coronavirus neutralization.
Sauer, M.M., Tortorici, M.A., Park, Y.J., Walls, A.C., Homad, L., Acton, O.J., Bowen, J.E., Wang, C., Xiong, X., de van der Schueren, W., Quispe, J., Hoffstrom, B.G., Bosch, B.J., McGuire, A.T., Veesler, D.(2021) Nat Struct Mol Biol 28: 478-486
- PubMed: 33981021 
- DOI: 10.1038/s41594-021-00596-4
- Primary Citation of Related Structures:  
7M51, 7M52, 7M53, 7M55, 7M5E - PubMed Abstract: 
Three highly pathogenic β-coronaviruses have crossed the animal-to-human species barrier in the past two decades: SARS-CoV, MERS-CoV and SARS-CoV-2. To evaluate the possibility of identifying antibodies with broad neutralizing activity, we isolated a monoclonal antibody, termed B6, that cross-reacts with eight β-coronavirus spike glycoproteins, including all five human-infecting β-coronaviruses ...